A detailed history of Pitcairn CO transactions in Insmed Inc stock. As of the latest transaction made, Pitcairn CO holds 5,100 shares of INSM stock, worth $823,038. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,100
Previous 2,105 142.28%
Holding current value
$823,038
Previous $211,000 143.13%
% of portfolio
0.03%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 18, 2025

BUY
$64.81 - $105.9 $194,105 - $317,170
2,995 Added 142.28%
5,100 $513,000
Q2 2025

Aug 14, 2025

SELL
$64.81 - $105.9 $248,222 - $405,597
-3,830 Reduced 64.53%
2,105 $211,000
Q1 2025

May 09, 2025

SELL
$65.25 - $83.83 $5,546 - $7,125
-85 Reduced 1.41%
5,935 $452,000
Q4 2024

Feb 12, 2025

SELL
$66.29 - $76.63 $3,911 - $4,521
-59 Reduced 0.97%
6,020 $415,000
Q3 2024

Nov 12, 2024

SELL
$62.0 - $79.01 $79,298 - $101,053
-1,279 Reduced 17.38%
6,079 $443,000
Q2 2024

Aug 13, 2024

BUY
$22.0 - $69.71 $161,876 - $512,926
7,358 New
7,358 $492,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $21.9B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Pitcairn CO Portfolio

Follow Pitcairn CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.